Keyphrases
Tuberculosis Patients
100%
Indonesia
78%
Multidrug-resistant Tuberculosis (MDR-TB)
72%
Mycobacterium Tuberculosis (M. tb)
57%
Pulmonary Tuberculosis
54%
Tuberculosis
50%
Surabaya
40%
Bedaquiline
30%
Antibacterial Activity
26%
COVID-19
26%
Rifampicin
20%
TB Patients
19%
Risk Factors
19%
Rifampicin-resistant Tuberculosis
18%
Indonesian
17%
Sputum
17%
Acid-fast Bacilli
15%
Tuberculosis Treatment
14%
QT Prolongation
13%
QTc Interval
13%
Passiflora Edulis Sims
12%
Delamanid
12%
Tuberculosis Diagnosis
12%
Type 1 Diabetes Mellitus (T1DM)
12%
Active Tuberculosis
11%
Tertiary Referral Hospital
11%
Shorter Regimen
11%
Referral Hospital
11%
Xpert MTB
11%
Rifampicin Resistance
10%
Medical Records
10%
Escherichia Coli
10%
Antibiotics
10%
Intensive Phase
10%
Pulmonary TB Patients
9%
C-reactive Protein
9%
Lung Tuberculosis
9%
Red Passion Fruit
9%
Culture Method
9%
Multidrug-resistant
9%
Clinical Outcomes
8%
Academic Hospital
8%
N-acetyltransferase 2 (NAT2)
8%
East Java Indonesia
8%
Sputum Samples
8%
Anti-tuberculosis Drugs
8%
GeneXpert
8%
Lung Damage
8%
Chest X-ray
8%
Treatment Outcome
8%
Mycobacterium
7%
Moxifloxacin
7%
Inhibitory Activity
7%
General Hospital
7%
Latent Tuberculosis Infection
7%
Lactic Acid Bacteria
7%
Methicillin-resistant Staphylococcus Aureus
7%
Xpert
6%
Ag85B
6%
Staphylococcus Aureus
6%
Minimum Inhibitory Concentration
6%
Aqueous Extract
6%
Saccharum Officinarum
6%
Pneumonia Patients
6%
Population Pharmacokinetic Model
6%
Jember
6%
Cloning Expression
6%
Short-term Treatment
6%
Healthcare Workers
6%
Peripheral Blood Mononuclear Cells
6%
Inflammatory Cytokines
6%
Potential Biomarkers
6%
Fine-needle Aspiration Biopsy
6%
Antimicrobial Activity
6%
Extended-spectrum beta-lactamase-producing Escherichia Coli
6%
Lung Tissue Damage
6%
Multidrug-resistant Organisms
6%
Indonesian Patients
6%
Radiological Diagnosis
6%
Streptomyces Sp.
6%
Cell-free
6%
Corrected QT Interval
6%
Continuation Phase
6%
Drug-resistant Pulmonary Tuberculosis
5%
Pneumonia
5%
Antibacterial Agents
5%
Treatment Regimen
5%
16S Ribosomal RNA (16S rRNA)
5%
Fermentation
5%
Polymerase Chain Reaction
5%
Culture Results
5%
Streptomycin
5%
Healthy Controls
5%
Smear Positive
5%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Tuberculosis
63%
Mycobacterium Tuberculosis
53%
Drug Resistant Tuberculosis
48%
Rifampicin
35%
Diseases
34%
Bedaquiline
32%
Multi-Drug-Resistant Tuberculosis
21%
Antibacterial Activity
18%
Tuberculosis
16%
Infection
14%
Antiinfective Agent
13%
Side Effect
13%
Coronavirinae
12%
Delamanid
12%
Cross-Sectional Study
12%
Acid Fast Bacterium
11%
Moxifloxacin
10%
Infectious Agent
10%
Staphylococcus Aureus
10%
Retrospective Study
9%
Streptomyces
9%
Passiflora edulis
9%
Pharmacokinetics
9%
Atypical Mycobacterium
9%
Diabetes Mellitus
9%
Prevalence
8%
Escherichia coli
8%
Comorbidity
8%
Lung Injury
8%
Antimicrobial Resistance
7%
Flavonoid
7%
Isoniazid
7%
Biological Marker
7%
Isotopes of Potassium
7%
Microorganism
7%
Antibiotics
7%
Latent Tuberculosis
6%
Tuberculostatic Agent
6%
Mycobacteria
6%
Hibiscus sabdariffa
6%
C Reactive Protein
6%
Cytokine
6%
Adenosine Deaminase
6%
Tissue Injury
6%
Coconut
6%
Extrapulmonary Tuberculosis
6%
Antimicrobial Agent
6%
Extended Spectrum Beta Lactamase
6%
Pharmacotherapy
6%
Tumor Necrosis Factor
5%
Clofazimine
5%
Multidrug Resistance
5%
Minimum Inhibitory Concentration
5%
Medicine and Dentistry
Lung Tuberculosis
37%
Mycobacterium Tuberculosis
30%
Sputum
26%
Drug Resistant Tuberculosis
26%
COVID-19
25%
Diseases
14%
Bedaquiline
14%
Rifampicin
12%
Multidrug Resistant Tuberculosis
12%
Acid Fast Bacterium
10%
Diagnosis
9%
Diabetes Mellitus
9%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Infection
8%
Patient Referral
8%
Tuberculostatic Agent
7%
Extrapulmonary Tuberculosis
7%
Mixed Infection
7%
Tuberculosis
7%
QTc Interval
7%
Sputum Culture
6%
C Reactive Protein
6%
Adenosine Deaminase
6%
Systematic Review
6%
Delamanid
6%
Tuberculous Lymphadenitis
6%
Intensive Care Unit
6%
Culture Conversion
6%
Atypical Mycobacterium
6%
Retrospective Study
6%
Cross Sectional Study
6%
Medical Record
5%
Lymphadenitis
5%
Lung
5%
Fine-Needle Aspiration
5%